Skip to content
OpenCapital
Get started

Arcadia Biosciences RKDA Q4 2025 Annual earnings

Reported March 26, 2026 · Before market open

Revenue$901.0KMiss by $499.0K
EPS-$0.98Miss by $0.32
Revenue estimate$1.4M
EPS estimate-$0.66

Next report

Aug 19, 2026 (In 2 weeks)
Revenue estimate$1.9M
EPS estimate-$0.56

Versus estimates

Revenue

Q1 2026$1.1MMiss by $500.0K
Q4 2025$901.0KMiss by $499.0K
Q3 2025$1.3MMiss by $598.0KQ2 2025$1.5MMiss by $745.0KQ1 2025$1.2MMiss by $100.0KQ4 2024$1.2MBeat by $66.0K

Diluted EPS

Q1 2026-$2.11Miss by $1.31
Q4 2025-$0.98Miss by $0.32
Q3 2025$0.62Beat by $1.16Q2 2025$0.02Beat by $0.81Q1 2025$1.90Beat by $2.88Q4 2024-$2.48Miss by $1.59

Ask the moment Arcadia Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Arcadia Biosciences report Q4 2025 earnings?
Arcadia Biosciences (RKDA) reported Q4 2025 earnings on March 26, 2026 before market open.
What were Arcadia Biosciences's Q4 2025 revenue and EPS?
Arcadia Biosciences reported revenue of $901.0K and eps of $-0.98 for Q4 2025.
Did Arcadia Biosciences beat estimates in Q4 2025?
Revenue missed the consensus estimate of $1.4M by $499.0K. EPS missed the consensus estimate of $-0.66 by $0.32.
How did Arcadia Biosciences's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 25.9% from $1.2M a year earlier and eps grew 60.5% from $-2.48.
Where can I find Arcadia Biosciences's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-126220) and the 10-K periodic report (0001193125-26-126238) directly on SEC EDGAR. The filing index links above go to sec.gov.